Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

Efficacy of Modified Melphalan and Busulfan-Based Conditioning Regimen for ASCT in Patients with Low- or Intermediate-Risk AML

Shulian Chen, Xiaoyu Zhang, Yi He, Sizhou Feng, Mingzhe Han, Xingli Zhao, Jie Bai, Lijuan Li, Zhihua Zhang, Wang Ying, Jianxiang Wang, Weihua Zhai, Erlie Jiang

Blood (2024) 144 (Supplement 1): 6054.

https://doi.org/10.1182/blood-2024-202404

Published: 2024

Journal Articles

Efficacy and Safety of Hetrombopag in the Treatment of Chemotherapy-Induced Thrombocytopenia in Pediatric Acute Leukemia

Chunhui Yang, Runxiu Yin, Lijuan Li, Chunyan Song, Huiyuan Li, Zugang Xiao, Shaoqin Duan, Xin Tian

Blood (2024) 144 (Supplement 1): 5422.

https://doi.org/10.1182/blood-2024-204421

Published: 2024

Journal Articles

Efficacy and Safety of Different TPO-RAs Combined with Cyclosporine in the Treatment of NSAA

Ting Wang, Donglan Liu, Nianbin Li, Shuai Gao, Lijuan Li, Jia Song, Huaquan Wang, Rong Fu

Blood (2024) 144 (Supplement 1): 5691.

https://doi.org/10.1182/blood-2024-209539

Published: 2024

Journal Articles

Zanubrutinib, Lenalidomide, Rituximab, Temozolomide and Methotrexate (RLZT ± MTX) As First-Line Treatment for Newly Diagnosed PCNSL: A Prospective, Open-Label, Multicenter Clinical Trial

Rong Fu, Jia Song, Hui Liu, Zongjiu Jiao, Da Gao, Kai Ding, Jie Zhuo, Huijuan Jiang, Shan Gao, Yue Ren, Lijuan Li, Yihao Wang

Blood (2024) 144 (Supplement 1): 7786.

https://doi.org/10.1182/blood-2024-209056

Published: 2024

Journal Articles

The Efficacy of Modified Melphalan and Busulfan-Based Conditioning Regimen for Autologous-HSCT in Low-Risk and Intermediate-Risk AML Patients

Weihua Zhai, Shulian Chen, Xiaoyu Zhang, Yi He, Sizhou Feng, Mingzhe Han, Xingli Zhao, Jie Bai, Lijuan Li, Zhihua Zhang, Ying Wang, Erlie Jiang, Jianxiang Wang

Blood (2023) 142 (Supplement 1): 7073.

https://doi.org/10.1182/blood-2023-180077

Published: 2023

Journal Articles

Zanubrutinib, Lenalidomide, Rituximab, Temozolomide and Methotrexate (RLZT±MTX) As First-Line Treatment for Newly Diagnosed PCNSL: A Prospective, Open-Lable, Multicenter Clinical Trial

Jia Song, Hui Liu, Zongjiu Jiao, Da Gao, Kai Ding, Yihao Wang, Hong Yu, Yuanyuan Shao, Huijuan Jiang, Shan Gao, Lijuan Li, Rong Fu, Zonghong Shao

Blood (2022) 140 (Supplement 1): 3739–3740.

https://doi.org/10.1182/blood-2022-164677

Published: 2022

Journal Articles

Study of TIM-3 in Pathogenesis of Myelodysplastic Syndrome

Pei Liu, Zonghong Shao, MD, Lijuan Li, MD, Jinglian Tao, MD, Huaquan Wang, MD, Rong Fu, PhD

Blood (2018) 132 (Supplement 1): 4388.

https://doi.org/10.1182/blood-2018-99-114343

Published: 2018

Journal Articles

Whole-Exome Sequencing of Paroxysmal Nocturnal Hemoglobinuria

Rong Fu, PhD, Liyan LI, Hui Liu, Yun Liu, PhD, Lijuan Li, MD, Kai Ding, MD, Zonghong Shao, MD

Blood (2017) 130 (Supplement 1): 3475.

https://doi.org/10.1182/blood.V130.Suppl_1.3475.3475

Published: 2017

Journal Articles

Zoledronic Acid Inhibits Cell Growth of Multiple Myeloma Cells and Shows Synergistic Antimyeloma Effects with Bortezomib Via CD38 /cADPR /Ca2+ /Ras /Pakt /NF-Kb /Pim-2 Pathway

Rong Fu, MD, Zhaoyun Liu, Hui Liu, Jia Song, Guojin Wang, Yihao Wang, Lijuan Li, Zonghong Shao, MD

Blood (2015) 126 (23): 5311.

https://doi.org/10.1182/blood.V126.23.5311.5311

Published: 2015

Journal Articles

Decreased Tim-3 Expression Level of Peripheral Blood Natural Killer Cells in Severe Aplastic Anemia

Rong Fu, MD, Xin Yuan, Chunyan Liu, Hui Liu, Yihao Wang, Tong Chen, Lijuan Li, Jia Song, Guojin Wang, Zonghong Shao, MD

Blood (2015) 126 (23): 4767.

https://doi.org/10.1182/blood.V126.23.4767.4767

Published: 2015

Journal Articles

The Dysfunction of Platelets in Paroxysmal Nocturnal Hemoglobinuria

Rong Fu, PhD, Yinping Meng, Yihao Wang, Hui Liu, Yi Liu, Lijuan Li, Shaoxue Ding, Erbao Ruan, MD, Huaquan Wang, MD, Guojin Wang, Jia Song, Zonghong Shao, MD

Blood (2015) 126 (23): 4532.

https://doi.org/10.1182/blood.V126.23.4532.4532

Published: 2015

Journal Articles

The Expressions of CD114, CD117 and STAT5 in CD34+CD59− and CD34+CD59+ Bone Marrow Cells of the Patients with Paroxysmal Nocturnal Hemoglobinuria

Rong Fu, PhD, Shaoxue Ding, MD, Zonghong Shao, MD, Lijuan Li, PhD, Hui Liu, PhD, Honglei Wang, MD, Tian Zhang, MD

Blood (2012) 120 (21): 4404.

https://doi.org/10.1182/blood.V120.21.4404.4404

Published: 2012

Journal Articles

TET2 Gene Expression in Bone Marrow Cells in Myelodysplastic Syndromes Patients and the Effect of Silencing TET2 by siRNA On Biological Characteristics of Healthy CD34+ Cells

Zonghong Shao, MD, Wei Zhang, PhD, Rong Fu, PhD, Lijuan Li, PhD, Huaquan Wang, PhD

Blood (2012) 120 (21): 4934.

https://doi.org/10.1182/blood.V120.21.4934.4934

Published: 2012

Journal Articles

Expression and Clinical Significance of Notch1 On the Membrane of Bone Marrow CD38+CD138+Plasma Cells in the Patients with Multiple Myeloma

Rong Fu, PhD, Yiran Zhao, MD, Zonghong Shao, MD, Honglei Wang, MD, Tian Zhang, MD, Lijuan Li, PhD, Hui Liu, PhD

Blood (2012) 120 (21): 4981.

https://doi.org/10.1182/blood.V120.21.4981.4981

Published: 2012

Journal Articles

Efficacy and Safety of Monoclonal Anti-CD20 Antibody Rituximab Combined Cyclophosphamide in Treatment of Refractory and Recurrent Autoimmune Hemolytic Anemia

Zonghong Shao, MD, Hong Liu, PhD, Limin Xing, PhD, Yuhong Wu, MD, Wen Qu, MD, Yong Liang, PhD, Jing Guan, MD, Guojin Wang, MD, Xiaoming Wang, MD, Jia Song, PhD, Lijuan Li, PhD, Huaquan Wang, PhD

Blood (2012) 120 (21): 5161.

https://doi.org/10.1182/blood.V120.21.5161.5161

Published: 2012

Journal Articles

TET2 mRNA Expression in Bone Marrow Mononuclear Cells of the Patients with Myelodysplastic Syndromes and it's Clinical Significances

Zonghong Shao, MD, Wei Wang, MD, Rong Fu, MD, Jun Wang, MD, Lijuan Li, MD, Erbao Ruan, MD, Wen Qu, MD, Yong Liang, MD, Guojin Wang, MD, Xiaoming Wang, MD, Hong Liu, MD, Jia Song, MD, Yuhong Wu, MD, Limin Xing, MD, Jing Guan, MD, Huaquan Wang, MD

Blood (2011) 118 (21): 5036.

https://doi.org/10.1182/blood.V118.21.5036.5036

Published: 2011

Journal Articles

Expression of dlk1 in the Bone Marrow Cells of Patients with Myelodysplastic Syndrome and Its Clinical Significance

Zonghong Shao, MD, Lanzhu Yue, MD, Rong Fu, MD, Lijuan Li, MD, Erbao Ruan, MD, Wen Qu, MD, Yong Liang, MD, Guojin Wang, MD, Xiaoming Wang, MD, Hong Liu, MD, Jia Song, MD, Yuhong Wu, MD, Limin Xing, MD, Jun Wang, MD, Jing Guan, MD, Huaquan Wang, MD

Blood (2011) 118 (21): 5042.

https://doi.org/10.1182/blood.V118.21.5042.5042

Published: 2011

Journal Articles

The Somatic Mutation of PIG-A Gene and the Expressions of EGR-1 and WT1 Genes in Bone Marrow Cells of the Patients with Paroxysmal Nocturnal Hemoglobinuria

Rong Fu, MD, Liyan Li, MD, Zonghong Shao, MD, Jun Wang, MD, Lijuan Li, MD, Hui Liu, MD

Blood (2011) 118 (21): 4379.

https://doi.org/10.1182/blood.V118.21.4379.4379

Published: 2011

Journal Articles

Study on the Quantities and Functions of Natural Killer Cell Subsets in Peripheral Blood of the Patients with Severe Aplastic Anemia,

Zonghong Shao, MD, Zhishang Li, MD, Rong Fu, MD, Jun Wang, MD, Lijuan Li, MD, Tian Zhang, MD, Yuhong Wu, MD, Limin Xing, MD, Jia Song, MD, Huaquan Wang, MD

Blood (2011) 118 (21): 3423.

https://doi.org/10.1182/blood.V118.21.3423.3423

Published: 2011

Journal Articles

Preliminary Study of the Autoantigens on the Membrane of Erythropoietic Cells of the Patients with BMMNC- Coomb’s Test(+) Hemocytopenia

Rong Fu, MD, Hui Liu, MD, Zonghong Shao, MD, Jun Wang, MD, Lijuan Li, MD

Blood (2011) 118 (21): 4382.

https://doi.org/10.1182/blood.V118.21.4382.4382

Published: 2011

NARROW

Efficacy of Modified Melphalan and Busulfan-Based Conditioning Regimen for ASCT in Patients with Low- or Intermediate-Risk AML

Efficacy and Safety of Hetrombopag in the Treatment of Chemotherapy-Induced Thrombocytopenia in Pediatric Acute Leukemia

Efficacy and Safety of Different TPO-RAs Combined with Cyclosporine in the Treatment of NSAA

Zanubrutinib, Lenalidomide, Rituximab, Temozolomide and Methotrexate (RLZT ± MTX) As First-Line Treatment for Newly Diagnosed PCNSL: A Prospective, Open-Label, Multicenter Clinical Trial

The Efficacy of Modified Melphalan and Busulfan-Based Conditioning Regimen for Autologous-HSCT in Low-Risk and Intermediate-Risk AML Patients

Zanubrutinib, Lenalidomide, Rituximab, Temozolomide and Methotrexate (RLZT±MTX) As First-Line Treatment for Newly Diagnosed PCNSL: A Prospective, Open-Lable, Multicenter Clinical Trial

Study of TIM-3 in Pathogenesis of Myelodysplastic Syndrome

Whole-Exome Sequencing of Paroxysmal Nocturnal Hemoglobinuria

Zoledronic Acid Inhibits Cell Growth of Multiple Myeloma Cells and Shows Synergistic Antimyeloma Effects with Bortezomib Via CD38 /cADPR /Ca2+ /Ras /Pakt /NF-Kb /Pim-2 Pathway

Decreased Tim-3 Expression Level of Peripheral Blood Natural Killer Cells in Severe Aplastic Anemia

The Dysfunction of Platelets in Paroxysmal Nocturnal Hemoglobinuria

The Expressions of CD114, CD117 and STAT5 in CD34+CD59− and CD34+CD59+ Bone Marrow Cells of the Patients with Paroxysmal Nocturnal Hemoglobinuria

TET2 Gene Expression in Bone Marrow Cells in Myelodysplastic Syndromes Patients and the Effect of Silencing TET2 by siRNA On Biological Characteristics of Healthy CD34+ Cells

Expression and Clinical Significance of Notch1 On the Membrane of Bone Marrow CD38+CD138+Plasma Cells in the Patients with Multiple Myeloma

Efficacy and Safety of Monoclonal Anti-CD20 Antibody Rituximab Combined Cyclophosphamide in Treatment of Refractory and Recurrent Autoimmune Hemolytic Anemia

TET2 mRNA Expression in Bone Marrow Mononuclear Cells of the Patients with Myelodysplastic Syndromes and it's Clinical Significances

Expression of dlk1 in the Bone Marrow Cells of Patients with Myelodysplastic Syndrome and Its Clinical Significance

The Somatic Mutation of PIG-A Gene and the Expressions of EGR-1 and WT1 Genes in Bone Marrow Cells of the Patients with Paroxysmal Nocturnal Hemoglobinuria

Study on the Quantities and Functions of Natural Killer Cell Subsets in Peripheral Blood of the Patients with Severe Aplastic Anemia,

Preliminary Study of the Autoantigens on the Membrane of Erythropoietic Cells of the Patients with BMMNC- Coomb’s Test(+) Hemocytopenia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only